Skip to main content

Table 1 Clinical characteristics of the study participants

From: Low apoA-I is associated with insulin resistance in patients with impaired glucose tolerance: a cross-sectional study

Parameters IGT group (n = 108) Control group (n = 84) P value
Sex (M/F) 65/43 44/40 0.279
Age (years) 57.31 ± 7.21 56.83 ± 7.55 0.651
BMI (kg/m2) 26.43 ± 4.83 24.26 ± 3.44 0.001
SBP (mmHg) 128.11 ± 6.86 126.46 ± 6.89 0.101
DBP (mmHg) 75.62 ± 6.50 74.14 ± 7.38 0.142
TC (mmol/L) 5.15 ± 1.06 4.92 ± 0.91 0.109
HDL-C (mmol/L) 1.34 ± 0.27 1.58 ± 0.37 <0.001
LDL-C (mmol/L) 3.10 ± 0.74 2.85 ± 0.75 0.024
TG (mmol/L) 2.37 (1.99, 2.79) 1.09 (0.71, 1.48) <0.001
ApoA-I (g/L) 1.37 ± 0.36 1.57 ± 0.39 <0.001
ApoB (g/L) 0.97 ± 0.22 0.90 ± 0.23 0.030
ApoA-I/HDL-C 0.99 (0.91, 1.10) 0.99 (0.85, 1.11) 0.821
FBG (mmol/L) 6.30 (5.60, 6.98) 5.58 (5.24, 5.82) <0.001
2hPG (mmol/L) 9.30 (8.63, 9.80) 6.50 (6.08, 6.73) <0.001
HbA1c (%) 6.30 (6.00, 6.40) 5.90 (5.60, 6.10) <0.001
FINS (mIU/L) 15.70 (10.80, 18.30) 8.17 (5.39, 11.97) <0.001
HOMA-IR 4.21 ± 1.56 2.15 ± 0.99 <0.001
  1. IGT group, patientswith impaired glucose tolerance; Control group, control subjects; BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, TG triglycerides, apoA-I apolipoprotein A-I, apoB apolipoprotein B, FBG fasting blood glucose, 2hPG 2-h postchallenge glucose, HbA1c glycated hemoglobin, FINS fasting insulin, HOMA-IR homeostasis model assessment of insulin resistance